SUMMARY In this study we have characterised by oligonucleotide hybridisation and direct restriction endonuclease analysis the thalassaemia mutation in 494 Sardinian thalassaemia heterozygotes. The most prevalent mutation, accounting for 95-4% of the cases, was the nonsense mutation at codon 39. The remainder, in decreasing order of frequency, were a frameshift at codon 6 (2-2%), 13+ IVS-1, nt 110 (0-4%), and ,13 IVS-2, nt 745 (0-4%). This information allows prenatal diagnosis by DNA analysis to be made in the great majority of Sardinian couples at risk for 13 thalassaemia.
In the Sardinian population, one 1 thalassaemia mutation, namely a C-T substitution at the codon corresponding to amino acid 39 (1339), is widely prevalent accounting for the majority (95%) of cases of thalassaemia major and intermedia.' 2 Prenatal diagnosis in this population is therefore carried out at present in the great majority of cases by the analysis of amniocyte or chorionic villus DNA with an oligonucleotide probe able to detect the 13039 mutation. 3 The remaining cases, in whom the molecular defect has not yet been characterised, are monitored by fetal blood analysis.5
In order to extend prenatal diagnosis by DNA analysis to carriers of the less frequent mutations, in the present study we investigated the molecular basis of 13 thalassaemia in a group of 13 thalassaemia chromosomes from Sardinians in whom we excluded the presence of the 13039 mutant. We found that in the non-1339 thalassaemia chromosomes, the most frequent mutation was the single nucleotide deletion at the GAG codon of the 1-6 position (frameshift 6) of the 13 The polymorphic restriction enzyme sites studied were: HincII 3' to the E globin gene, 13 HindIII within the Gy and Ay globin genes,'4 HincII within and 5' to the VP globin gene,'3 Avall within the second intervening sequence of the 3 globin gene, '5 and BamHI 3' to the ( globin gene.'6
The presence of a polymorphic site is indicated as (+) and its absence as (-) . The All the spouses of thalassaemia heterozygotes with the frameshift at codon 6 had the 13039 mutant. Prenatal diagnosis was undertaken in these cases, therefore, with the combination of oligonucleotide
The results of this study confirm that the most prevalent thalassaemia mutation in Sardinians is the 13039 mutant,3 4 which accounts for 95% of thalassaemia chromosomes. In the remainder, we detected the frameshift at codon 6 in 2*2%, the 13+ IVS-1, nt 110 in 0*4%, and the IVS-2, nt 745 in 0.4%. The relative frequencies of the different mutations found in this study contrast with the distribution observed in an American population of mixed Mediterranean background20 in which the 13+ IVS-1, nt 110 was the most frequent mutation followed by the 1339. This difference may be explained by the relative isolation of the Sardinian population since these mutations arose.
A frameshift at codon 6 was found to be associated more commonly with haplotype IX and rarely with haplotype I. Previous studies in Mediterranean people have shown this mutation associated with haplotypes I, IX, or V.8 20 Our results confirm, therefore, the existence of a close association between specific thalassaemia mutations and haplotypes.
Oligonucleotide hybridisation and direct restriction endonuclease analysis allowed us to characterise the thalassaemia mutation in 65% of the non-13039 thalassaemia chromosomes in Sardinians, confirming the validity of this approach for the delineation of specific thalassaemia defects in a population. Cloning and sequence analysis of the The results from this study are also relevant to the planning of prenatal diagnosis in a multiracial population. According to our studies a a thalassaemia heterozygote of Sardinian origin requesting prenatal diagnosis should be investigated first for the presence of the 139 mutant and second for a frameshift at codon 6, both of which may be easily detected by DNA analysis. prenatal diagnosis. 
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